These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7154096)

  • 1. Protection from irreversible hypoxic injury by potassium cardioplegia and hypothermia: effects on contracture, morphology and O2-enzyme release.
    Ganote CE; Angelo J; Safavi S; Kaltenbach JP
    J Mol Cell Cardiol; 1982 Oct; 14(10):587-99. PubMed ID: 7154096
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxygen-induced enzyme release after irreversible myocardial injury. Effects of cyanide in perfused rat hearts.
    Ganote CE; Worstell J; Kaltenbach JP
    Am J Pathol; 1976 Aug; 84(2):327-50. PubMed ID: 941982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of caffeine-induced injury in Ca2+-free perfused rat hearts. Relationship to the calcium paradox.
    Vander Heide RS; Altschuld RA; Lamka KG; Ganote CE
    Am J Pathol; 1986 May; 123(2):351-64. PubMed ID: 3706496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does potassium potentiate profound hypothermic cardioplegia for myocardial preservation?
    Schachner A; Siegel JH; Schimert G; Lajos TZ; Lee AB; Schaefer P; Korenyi-Both A; Montes M; Vladutiu A
    Surgery; 1978 Jul; 84(1):94-103. PubMed ID: 307282
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypothermic potassium cardioplegia preserves myocardial compliance.
    Ellis RJ; Mangano DT; Van Dyke DC; Ebert PA
    Surgery; 1979 Dec; 86(6):810-7. PubMed ID: 316205
    [No Abstract]   [Full Text] [Related]  

  • 6. The additive protective effects of hypothermia and chemical cardioplegia during ischemic cardiac arrest in the rat.
    Hearse DJ; Stewart DA; Braimbridge MV
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):39-43. PubMed ID: 7350387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myocardial metabolism during coronary perfusion at 10 degrees C with or without cardioplegia associated with potassium].
    Mikaeloff P; Amouroux C; Boivin J; Guidollet J; Vial C; El Kirat M
    Arch Mal Coeur Vaiss; 1980 Sep; 73(9):1075-85. PubMed ID: 6776926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parallel temperature dependence of contracture-associated enzyme release due to anoxia, 2,4-dinitrophenol (DNP), or caffeine and the calcium paradox.
    Ganote CE; Sims MA
    Am J Pathol; 1984 Jul; 116(1):94-106. PubMed ID: 6742111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cold-blood potassium cardioplegia: evaluation of glutathione and postischemic cardioplegia.
    Standeven JW; Jellinek M; Menz LJ; Hahn JW; Barner HB
    J Thorac Cardiovasc Surg; 1979 Dec; 78(6):893-907. PubMed ID: 502572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advantages of potassium cardioplegia and perfusion hypothermia in left ventricular hypertrophy.
    Ellis RJ; Pryor W; Ebert A
    Ann Thorac Surg; 1977 Oct; 24(4):229-306. PubMed ID: 143917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cold blood potassium cardioplegia. Effects of increasing concentrations of potassium.
    Jellinek M; Standeven JW; Menz LJ; Hahn JW; Barner HB
    J Thorac Cardiovasc Surg; 1981 Jul; 82(1):26-37. PubMed ID: 7242128
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative study of myocardial protection by coronary perfusion in deep hypothermia (10 degrees C) with or without potassium cardioplegia. Clinical, electrocardiographic, enzymatic results; biochemical and histological controls].
    Mikaeloff P; Amouroux C; Boivin J; Loire R; Vial C; Guidollet G; Font B; Goldschmidt D; Van Haecke P; Bouillot A
    Arch Mal Coeur Vaiss; 1980 Jun; 73(6):701-12. PubMed ID: 6779764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anoxia, calcium and contracture as mediators of myocardial enzyme release.
    Ganote CE; Liu SY; Safavi S; Kaltenbach JP
    J Mol Cell Cardiol; 1981 Jan; 13(1):93-106. PubMed ID: 7253032
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the protective properties of four clinical crystalloid cardioplegic solutions in the rat heart.
    Robinson LA; Braimbridge MV; Hearse DJ
    Ann Thorac Surg; 1984 Sep; 38(3):268-74. PubMed ID: 6476950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium antagonists and myocardial protection during cardioplegic arrest.
    Yamamoto F; Manning AS; Braimbridge MV; Hearse DJ
    Adv Myocardiol; 1985; 6():545-62. PubMed ID: 3992050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.
    Lu K; Otani H; Yamamura T; Nakao Y; Hattori R; Ninomiya H; Osako M; Imamura H
    J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dimethylsulfoxide (DMSO) on the oxygen paradox in perfused rat hearts.
    Ganote CE; Sims M; Safavi S
    Am J Pathol; 1982 Dec; 109(3):270-6. PubMed ID: 6817643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of the chronic hypoxic immature rat heart during global ischemia.
    Karck M; Ziemer G; Zoeller M; Schulte S; Juergens KD; Weisser H; Haverich A
    Ann Thorac Surg; 1995 Mar; 59(3):699-706. PubMed ID: 7887715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial injury associated with potassium arrest.
    Engelman RM; Baumann G; Boyd AD; Kaplan F
    Ann Thorac Surg; 1976 Dec; 22(6):557-71. PubMed ID: 999381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of myocardial protection with nifedipine and potassium.
    Magee PG; Flaherty JT; Bixler TJ; Glower D; Gardner TJ; Bukley BH; Gott VL
    Circulation; 1979 Aug; 60(2 Pt 2):151-7. PubMed ID: 445771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.